Role of catecholamine and adenosine in the ischemic response following release of a renal artery occlusion.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure; D002395:Catecholamines / Q000502:physiology*; D003404:Creatinine / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007042:Hypoxanthines / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D009705:Nucleosides / Q000502:physiology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D012077:Renal Artery / Q000502:physiology*; D012078:Renal Artery Obstruction / Q000503:physiopathology*; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014666:Vasomotor System / Q000502:physiology
D002395:Catecholamines; D006584:Hexamethonium Compounds; D007042:Hypoxanthines; D009705:Nucleosides; D010643:Phenoxybenzamine; D000804:Angiotensin II; D012701:Serotonin; D004176:Dipyridamole; D001285:Atropine; D012110:Reserpine; D003404:Creatinine; D014043:Tolazoline; D000109:Acetylcholine; D009638:Norepinephrine; D014439:Tyramine